Laboratory monitoring of HIV - After access to antiretroviral drugs, the next challenge for the developing world [3]

South African Medical Journal

Volumn 91, Issue 8, 2001, Pages 615-

  Tucker, T ^a   Yeats, J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DEVELOPING COUNTRY; DISEASE COURSE; DISEASE TRANSMISSION; DRUG COST; DRUG EFFICACY; DRUG INDUSTRY; EPIDEMIC; EUROPE; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY; LETTER; LIFESPAN; NORTH AMERICA; PATENT; PATIENT CARE; PATIENT MONITORING; QUALITY CONTROL; SOUTH AFRICA; TIME; VIRUS LOAD;

ANTI-HIV AGENTS; CD4 LYMPHOCYTE COUNT; DEVELOPING COUNTRIES; DRUG COSTS; DRUGS, GENERIC; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HUMANS; SOUTH AFRICA; VIRAL LOAD;

EID: 0034871463     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma
2. Viral load and heterosexual transmission of human immunodeficiency virus type 1
3. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine